Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like The Industrial Internet Consortium and the Internet of Things Alliance Australia Announce Liaison August 8, 2018 “Flap-Free” Aircraft Soars on Supersonic Air May 16, 2019 The Case of Art to Part: The Rise of Systemic Intent Based Design with 3D Digital Manufacturing July 24, 2019
The Industrial Internet Consortium and the Internet of Things Alliance Australia Announce Liaison August 8, 2018
The Case of Art to Part: The Rise of Systemic Intent Based Design with 3D Digital Manufacturing July 24, 2019